tiprankstipranks
Trending News
More News >
Transgene SA (FR:TNG)
:TNG
France Market
Advertisement

Transgene (TNG) Drug Pipeline

Compare
4 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Tg6050
Non-small Cell Lung Cancer
Phase I
Terminated
A Clinical Trial of TG6050 in Patients With Metastatic Non-Small Cell Lung Cancer (Delivir)
Mar 15, 2023
Tg4050
Squamous Cell Carcinoma Of Head And Neck
Phase I/II
Active Not Recruiting
A Clinical Trial Evaluating TG4050 in Head and Neck Cancer
Nov 21, 2019
Tg4050
Fallopian Tube Cancer, Ovarian Carcinoma, Peritoneal Carcinoma
Phase I
Completed
A Trial Evaluating TG4050 in Ovarian Carcinoma.
Feb 06, 2019
Avelumab, Tg4001
Hpv-Related Cervical Carcinoma, Hpv-Related Carcinoma, Hpv-Related Anal Squamous Cell Carcinoma, Hpv-Related Penile Squamous Cell Carcinoma, Hpv-Related Vulvar Squamous Cell Carcinoma
Phase I/II
Active Not Recruiting
Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers
Aug 17, 2017

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does Transgene SA (TNG) have in its pipeline
      TNG is currently developing the following drugs: Tg6050, Tg4050, Tg4050. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis